Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.05 -1.86%
Revenue Growth %: +21.2%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
RBKB, ASBH, CMSG, More
Revenue Growth %: +21.2%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
RBKB, ASBH, CMSG, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q1 EPS of $0.60, $0.18 better than the analyst estimate of $0.42. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $185.15 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Consensus Mining & Seigniorage Corporation (CMSG) Tops Q3 EPS by 331c
- Bayfirst Financial Corp (BAFN) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
